Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Fouad Chebib, MD, a Mayo Clinic nephrologist and expert on polycystic kidney disease, discusses the use of artificial intelligence (AI) in predicting kidney failure in patients with polycystic…
Amira Abdelrasoul, PhD, PEng, is an associate professor in the Department of Chemical and Biological Engineering and the Division of Biomedical Engineering at the University of Saskatchewan. She…
Chronic kidney disease often goes unnoticed until it reaches an advanced stage. Early detection can help treat and prevent the disease before it necessitates dialysis or kidney transplantation.…
Sheeram Akilesh, MD, PhD, discusses spatial transcriptomics and its application in studying kidney disease. He explains the concept of spatial transcriptomics, which involves deeply interrogating a tissue section…
Nephrologist Sumeska Thavarajah, MD, of Johns Hopkins, discusses the management of chronic kidney disease. She explains that medications are prescribed to treat risk factors that can speed up…
Terry J. Watnick, MD, professor of neurology and director of Maryland PKD Clinical Center of Excellence, explains that polycystic kidney disease (PKD) is a genetic disorder that causes…
Dinushika Mohottige, MD, a general nephrologist and assistant professor at the ICAHN School of Medicine at Mount Sinai, discusses the causes, symptoms, and treatments of kidney disease. The…
Nephrologist Sumeska Thavarajah, MD, of Johns Hopkins, discusses treatment options for end-stage kidney disease, also known as end-stage renal disease. The treatments include dialysis, transplantation, or medical management,…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, explains what to expect after a radical nephrectomy. The procedure can be done minimally invasively, either laparoscopically or robotically,…
Heather N. Reich, MD, CM, PhD, FRCPC, Oreopoulos-Baxter Division Director of Nephrology, University of Toronto, discusses translating new clinical trials in IgA nephropathy, a kidney disease. Dr Reich…
